Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Research ID

hum0240-v1Release info

Latest

Research title

Whole genome sequence analysis in patients with primary central nervous system lymphomas

Research overview

Aims
To explore molecular targets of primary central nervous system lymphoma (PCNSL)
Methods
Target amplicon sequencing analysis was performed using Target Capture technology (NGS) on Cancer Panel
Participants/materials
PCNSL patients
URL
N/A

Datasets

CartDataset IDType of dataAnalysis methodAccess criteriaDate published
JGAD000361NGS (Target Capture)
  • Targeted DNA sequencing
Controlled-access (Type I)2020-10-27

Data provider

Principal investigator
Ryuya Yamanaka
Affiliation
Laboratory of Molecular Targeted Therapy for Cancer, Kyoto Prefectural University of Medicine

Research projects

NameURL
Genome-wide analysis in patients with primary central nervous system lymphomas.
N/A

Grants

NameTitleProject number
KAKENHI Grant-in-Aid for Scientific Research (B)
Exploring molecular targets for primary central nervous system lymphomas based on genome-wide analysis.
  • 16H05441
KAKENHI Grant-in-Aid for Scientific Research (B)
Development of molecular targeted therapy for primary central nervous system lymphomas.
  • 24390347

Related publications

TitleDOIDataset ID
Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma
https://doi.org/10.18632/oncotarget.25463 (opens in a new tab)
Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma
https://doi.org/10.1371/journal.pone.0251272 (opens in a new tab)

Controlled access users

No use of the controlled access data has been recorded.